Loading quotes...

Forecast

The analysts' average price target is €165.60 (+2,588.31%). The median is €165.60 (+2,588.31%).

Buy	4
Hold	2
Sell	0

News Go to news feed

Flora Growth falls sharply after announcement of capital increase

Flora Growth’s stock plunged about 28.4% in after-hours trading after the company announced a guaranteed public offering of only new common shares. R.F. Lafferty & Co. is acting as bookrunner, and the offering is to be made under an already filed S-3 shelf registration. Flora Growth also announced a rename to ZeroStack and said it will in future describe itself as an asset manager focused on decentralized AI. Investors reacted with concerns about dilution; the timing and terms of the issuance remain dependent on market conditions. » More on de.investing.com
Flora Growth starts planned public offering of common stock

Flora Growth has announced a placed public offering of its common stock, with R.F. Lafferty & Co. as sole book-running manager. All shares offered are to come from the company’s existing holdings; size and price range were not disclosed. The offering is subject to market conditions and will be made pursuant to a previously filed shelf registration (Form S-3). Flora Growth plans to change its name to ZeroStack and, according to InvestingPro, has more liquid assets than debt but has recently seen dwindling cash reserves and revenue growth while still not yet profitable. » More on de.investing.com
Flora Growth reports quarterly loss per share of $9.05, revenue falls 21.8%

Flora Growth reported a loss per share of $9.05 for the quarter ended September 30, 2025 (prior year: -$10.92). Revenue fell to $9.8 million, down 21.81% from $12.5 million in the same quarter a year earlier. » More on finanzen.net

Financials

In the last quarter, FLORA GROWTH CORP. Aktie had revenue of €11.97m and net profit of -€21.57m

(EUR)	June 2026	YoY
Revenue	11.97m	4.67%
Gross profit	1.42m	40.95%
Net profit	-21.57m	953.95%
EBITDA	-21.26m	1,086.49%

Fundamentals

Metric	Value
Market capitalization	€3.78m
Number of shares	542.54k
52-week high/low	€42.07 - €5.25
Dividends	No
Beta	1.90
P/E ratio	-0.03
PEG ratio	0.00
P/B ratio	2.26
P/S ratio	1.70

Company profile

Flora Growth Corp., together with its subsidiaries, engages in the growth, cultivation, and development of medicinal cannabis and medicinal cannabis derivative products to pharmacies, medical clinics, and cosmetic companies worldwide. It cultivates, processes, and supplies medicinal-grade cannabis oil, and cannabis derived medical and wellness products; offers skincare and beauty products; develops plant-based and medical-grade pharmaceuticals, phytotherapeutics, and dietary supplements; and designs and markets loungewear made from hemp-derived fabric and materials. The company also manufactures, distributes, and retails cannabidiol (CBD) derived products, such as gummies, topicals, tinctures, and vape products; lifestyle wellness products, including edibles, bath and body, pets, sports recovery, etc.; provides cannabis consumption accessories, personal storage, and travel accessories for vape and dry herb categories; and offers juices, exotic fruits coated with chocolate, and chocolate bars, as well as dried fruits, beans, and pulp from Amazonian fruits in supermarkets, discount retailers, coffee shops, restaurants, and airports. In addition, it engages in the manufacturing, promotion, and distribution of beverage products; manufacture and sale of product formulations for pain relief; and development of pharmaceutical cannabinoid formula for the prevention of Sars-Cov-2. The company sells its products under the JustCBD, Vessel, Mind Naturals, Mambe, Stardog, Tonino Lamborghini, and Kalaya brands. Flora Growth Corp. was incorporated in 2019 and is headquartered in Toronto, Canada.

Name	FLORA GROWTH CORP. Aktie
CEO	Daniel Reis-Faria
Headquarters	Toronto, on Canada
Website	floragrowth.com
Sector	Materials
Industry	Chemicals
IPO	11/05/2021
Employees	64